HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway

BACKGROUND: Lung adenocarcinoma is one of the most common tumors, and cisplatin is frequently used in treating lung adenocarcinoma patients. This study aimed to look into the roles and mechanisms of HNF4G in cisplatin resistance of lung adenocarcinoma. MATERIALS & METHODS: Cisplatin resistance a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jiaqi, Zhao, Guangyin, Bian, Yunyi, Bi, Guoshu, Sui, Qihai, Zhang, Huan, Shi, Haochun, Shan, Guangyao, Huang, Yiwei, Chen, Zhencong, Wang, Lin, Zhan, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010171/
https://www.ncbi.nlm.nih.gov/pubmed/36923501
http://dx.doi.org/10.7717/peerj.14996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010171/
https://www.ncbi.nlm.nih.gov/pubmed/36923501
http://dx.doi.org/10.7717/peerj.14996

Ejemplares similares